Understand vancomycin trough monitoring, therapeutic drug monitoring, and vancomycin levels for optimal patient care. This resource covers clinical documentation requirements, medical coding guidelines, and healthcare best practices for vancomycin therapy, including vancomycin trough level interpretation and vancomycin toxicity management. Learn about vancomycin dosing, creatinine clearance calculations, and the importance of accurate laboratory results for effective vancomycin treatment and patient safety.
Also known as
Encounter for therapeutic drug monitoring
Monitoring of vancomycin levels for therapeutic efficacy.
Other long term drug therapy
Long-term use of vancomycin requiring monitoring.
Other abnormal findings of blood chemistry
Abnormal vancomycin levels necessitating monitoring.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is vancomycin trough monitoring for therapeutic drug monitoring?
Yes
Is there vancomycin toxicity?
No
Is there a reason other than therapeutic drug monitoring?
When to use each related code
| Description |
|---|
| Vancomycin Trough Monitoring |
| Vancomycin-Induced Nephrotoxicity |
| Red Man Syndrome (RMS) |
Vancomycin trough levels must be drawn at the appropriate time before the next dose for accurate monitoring and optimal therapeutic effect. Mistiming can lead to inaccurate results and dosing errors.
Medical record must clearly document the specific clinical indication for vancomycin therapy to support the necessity of trough monitoring and ensure compliance with guidelines. Missing documentation poses audit risks.
Vancomycin dosing and trough interpretation are highly dependent on renal function. Missing or inaccurate creatinine results can lead to inappropriate vancomycin management and potential adverse events.
Vancomycin trough level monitoring was performed today to optimize therapeutic efficacy and minimize the risk of nephrotoxicity. The patient is currently receiving vancomycin therapy for [Indication, e.g., Methicillin-resistant Staphylococcus aureus bacteremia, documented Clostridium difficile infection]. The vancomycin trough level obtained prior to the [Dose number, e.g., fourth] dose was [Trough level value with units, e.g., 15 mcg/mL]. This trough level is within the [Therapeutic range, e.g., target therapeutic range of 15-20 mcg/mL] for this patient's indication. The patient's renal function, assessed by [Renal function indicator, e.g., serum creatinine and estimated glomerular filtration rate], was noted to be [Renal function status, e.g., stable and within normal limits]. The patient tolerated the vancomycin therapy without any reported adverse events such as nephrotoxicity, ototoxicity, or red man syndrome. The current vancomycin dosing regimen of [Vancomycin dosage, route, and frequency, e.g., 1 gram IV every 12 hours] will be [Continued, adjusted, held - with rationale, e.g., continued as the trough level is within the therapeutic range]. Continued monitoring of vancomycin trough levels, renal function, and clinical response will be performed to ensure optimal therapeutic outcomes and patient safety. Vancomycin therapeutic drug monitoring is essential for effective treatment and adverse event mitigation.